Skip to content

Severe Sepsis/Septic Shock on Admission to the General Surgical ICU

Severe Sepsis/Septic Shock on Admission to the General Surgical ICU

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01363635
Enrollment
800
Registered
2011-06-01
Start date
2011-06-30
Completion date
2024-06-30
Last updated
2023-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatal Outcome, Multiple Organ Failure, Septic Shock

Keywords

severe sepsis/septic shock, organ failure, AKI, PMI, ALI, Stroke, ICU death

Brief summary

Severe sepsis/septic shock are serious complications of infection with high morbidity and mortality. Recent information showed that early and aggressive resuscitation may help improving survival and outcome especially the resuscitation within the first 3 hours. In surgical patients, either severe sepsis/septic shock bought them to the operating room or this sepsis might be found after surgery resulting in higher morbidity and mortality. Not only knowledge management, others possible risk factors should also be identified and corrected for outcome improving. This prospective observational study will be done in 800 adult surgical patients admitting to the general surgical intensive care unit. Incidence of severe sepsis/septic shock on admission along with risk factors associated with poor outcomes \[organ failure (AKI, ALI, PMI, liver failure, stroke), prolonged ICU length of, stay, ICU death\] will be recorded especially effect of amount and type of fluid replacement in the first 6 hours, 24, 48 and 72 hours after diagnosis. Outcome as major organ failure, ICU length of stay, ICU, 28 and 90 days mortality will also be study.

Detailed description

Consecutive severe sepsis/ septic shock patients who will be admitted to the general surgical ICU of Siriraj Hospital, Mahidol University, Bangkok, Thailand will be recruited to this study. Apart from demographic data (age, sex, BMI, comorbidity), detail of septic shock and resuscitation (preoperative and intraoperative resuscitation), vasopressor and steroid used, type and amount of fluid, blood and blood component used and shock reversal time. Complication associated with surgery, anesthesia and in ICU will also recorded. Clinical outcome as organ failure (Stroke, PMI, aki, ARDS); ventilator day, ICU and hospital length of stay, mortality (in ICU, 28 and 90 days mortality) and cause of mortality will be carefully recorded

Interventions

None listed

Sponsors

Mahidol University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Adult (\> 18 years) surgical patient admitting to the general surgical ICU * Consent to this study

Exclusion criteria

* Patient undergoing cardiothoracic surgery, neurosurgery and traumatic surgery * Not consent to this study

Design outcomes

Primary

MeasureTime frameDescription
incidence of severe sepsis/septic shock on admission to the general surgical ICU5 yearIncidence of severe sepsis and septic shock on admission to the general surgical ICU

Secondary

MeasureTime frameDescription
risk factors associated with poor outcome (organ failure, prolonged ICU length of stay and ICU death)5 yearorgan failure (Stroke, AKI, PMI,ARDS), Mortality (ICU, 28 and 90 days) mortality and cause of mortality

Countries

Thailand

Contacts

Primary ContactSuneerat Kongsayreepong, MD
suneerat.kon@mahidol.ac.th(661) 8427419
Backup ContactOnuma Chaiwat, MD
onuma27@hotmail.com(664)-3882104

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026